Literature DB >> 11122030

Role of drug exposure in aphthous ulcers: a case-control study.

S Boulinguez1, S Reix, C Bedane, C Debrock, M L Bouyssou-Gauthier, A Sparsa, V Le Brun, P De Vencay, P Bernard, J M Bonnetblanc.   

Abstract

BACKGROUND: Drug-induced aphthous ulcers have been the subject of several isolated and heterogeneous case reports for the last three decades.
OBJECTIVES: To perform a case-control study to evaluate the risks linked to drug exposure in aphthous ulcers.
METHODS: Eighty patients with typical clinical patterns of aphthous ulcers and 152 control patients who had had consultations for skin tumours were studied. A standardized questionnaire, concerning clinical features, life-style and medications taken during the last month, was completed for each patient.
RESULTS: Case patients had a much higher intake of medications than control patients, respectively, 5.1 and 2. 8 medications per patient (P < 0.0001). Multivariate paired analysis showed an association between aphthous ulcers and two classes of drugs: non-steroidal anti-inflammatory drugs (P < 0.001) and beta-blockers (P = 0.002). Smoking could have a protective effect against aphthous ulcers (P < 0.001).
CONCLUSIONS: Previous case reports and the results of this study suggest a real link between beta-blockers and aphthous ulcers. Our study did not confirm a role of other drugs but a few interesting case reports with positive reintroduction have to be considered. These results could be beneficial for patients, as healing may occur when the incriminated drug is discontinued.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122030     DOI: 10.1046/j.1365-2133.2000.03898.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

Review 1.  Recurrent aphthous stomatitis.

Authors:  Sunday O Akintoye; Martin S Greenberg
Journal:  Dent Clin North Am       Date:  2014-01-21

2.  Systemic and environmental risk factors for recurrent aphthous stomatitis in a Polish cohort of patients.

Authors:  Zuzanna Ślebioda; Barbara Dorocka-Bobkowska
Journal:  Postepy Dermatol Alergol       Date:  2018-03-26       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.